Wan Sun
Impact in
-
- Advanced Breast Cancer Therapies
-
- Chronic Lymphocytic Leukemia Research
- Inflammatory Bowel Disease
Papers in
-
- Advanced Breast Cancer Therapies 9
- Oncology 6
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Diane Wang (5 shared papers)Richard S. Finn (2 shared papers)Maha Kosa (1 shared paper)Anna Plotka (2 shared papers)Karen J. Klamerus (1 shared paper)Melissa O’Gorman (2 shared papers)Sylvester Pawlak (1 shared paper)Nicholas C. Turner (3 shared papers)
- Journals
- Journal of Crohn s and Colitis (3 papers)The Journal of Clinical Pharmacology (3 papers)Cancer Research (2 papers)BMC Plant Biology (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Wan Sun
23 papers receiving 333 citations
Peers
Comparison fields: 5 of 62
- Pulmonary and Respiratory Medicine 140
- Genetics 40
- Oncology 95
- Pharmaceutical Science 10
- Dermatology 13
Countries citing papers authored by Wan Sun
This map shows the geographic impact of Wan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Sun more than expected).
Fields of papers citing papers by Wan Sun
This network shows the impact of papers produced by Wan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Sun. The network helps show where Wan Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Wan Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 60 | |
| 2 | 2018 | 59 | |
| 3 | 2020 | 37 | |
| 4 | 2024 | 37 | |
| 5 | 2017 | 36 | |
| 6 | 2013 | 12 | |
| 7 | Influences of neoadjuvant chemotherapy on clinical indicators, prognosis and neutrophil/lymphocyte ratio of stage IB2-IIB cervical cancer. | 2021 | 12 |
| 8 | 2021 | 11 | |
| 9 | 2020 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2019 | 9 | |
| 12 | 2017 | 8 | |
| 13 | 2020 | 7 | |
| 14 | 2017 | 5 | |
| 15 | 2019 | 4 | |
| 16 | 2017 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2014 | 3 | |
| 19 | 2021 | 2 | |
| 20 | 2024 | 2 |
About Wan Sun
Wan Sun is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Molecular Biology and Genetics, having authored 24 papers that have together received 334 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (9 papers), Biosimilars and Bioanalytical Methods (4 papers), HER2/EGFR in Cancer Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Pharmaceutical studies and practices (3 papers), Inflammatory Bowel Disease (3 papers), Cancer Treatment and Pharmacology (2 papers) and Pregnancy and Medication Impact (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (140 citations), Genetics (40 citations), Oncology (95 citations), Pharmaceutical Science (10 citations) and Dermatology (13 citations). Wan Sun has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Diane Wang, Richard S. Finn, Maha Kosa, Anna Plotka, Karen J. Klamerus, Melissa O’Gorman, Sylvester Pawlak, Nicholas C. Turner, Geoffrey I. Shapiro and Angela DeMichele. Their work appears in journals such as Journal of Crohn s and Colitis, The Journal of Clinical Pharmacology, Cancer Research, BMC Plant Biology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.